BlackRock Global Funds - Global Equity Income Fund D2 USDRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.0 | 18.8 | -3.4 | 9.6 | 4.0 | |
+/-Cat | 1.1 | 0.5 | -2.6 | 2.4 | -0.3 | |
+/-B’mrk | - | -1.6 | -10.2 | 4.9 | -1.4 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 16/05/2024 | USD 26.42 | |
Day Change | 0.11% | |
Morningstar Category™ | Global Equity Income | |
ISIN | LU0545039975 | |
Fund Size (Mil) 30/04/2024 | USD 905.80 | |
Share Class Size (Mil) 15/05/2024 | USD 73.15 | |
Max Initial Charge | 5.26% | |
Ongoing Charge 09/02/2023 | 1.07% |
Investment Objective: BlackRock Global Funds - Global Equity Income Fund D2 USD |
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests globally at least 70% of its total assets in the equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, developed markets. Currency exposure is flexibly managed. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Olivia Treharne 01/02/2020 | ||
Molly Greenen 12/01/2022 | ||
Inception Date 24/11/2010 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - Global Equity Income Fund D2 USD | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.70 |
AstraZeneca PLC | Healthcare | 3.39 |
Novo Nordisk A/S Class B | Healthcare | 3.27 |
Taiwan Semiconductor Manufacturi... | Technology | 3.14 |
Texas Instruments Inc | Technology | 3.06 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds - Global Equity Income Fund D2 USD |